Skip to content

Chemical Peel · Medical Skin Care · Istanbul

Chemical Peel

Superficial, medium-depth and deep peels differ in tissue effect, recovery and monitoring and are not one routine skin-care method. A named care method, ingredient or infusion is not a diagnosis and does not establish personal suitability.

Online information cannot diagnose, select products or procedures, or promise an outcome. Final decisions require an in-person medical assessment.

Finding · identity · evidence · safety

Four questions precede a personal plan.

The sequence prevents a category name from becoming an automatic treatment recommendation.

01Clinical context

What is the finding?

Diagnosis, skin type, pigment and scar risk, infection, herpes history, medicines and previous procedures precede any peel.

02Identity

What exactly is proposed?

Agent, formulation, concentration, pH, layers or passes, contact time, neutralisation and intended depth are product- and protocol-specific.

03Evidence

What does the evidence support?

Benefits and harms cannot be generalised across peel depths, formulations, diagnoses or skin types.

04Safety

When should it stop?

Urgent review is required for eye exposure, severe pain, blistering, spreading redness, discharge, delayed healing or marked colour change.

Chemoexfoliation · Target layer · Healing

Peeling means controlled skin injury — not the strongest possible peeling.

Depending on the protocol, a defined chemical stimulus produces superficial or deeper renewal. Visible flaking alone does not show the actual treatment depth.

What a Chemical Peel can do

  • Be assessed for selected acne, superficial pigmentation or rough texture
  • Match the agent and depth to the diagnosis, phototype and available healing time
  • Form one limited step within a longer-term skin or pigmentation plan
  • Be linked to standardised photographs and a fixed review point

What a Chemical Peel cannot do

  • Treat unclear or changing pigmented lesions cosmetically without a diagnosis
  • Completely remove deep tethered acne scars or pronounced excess skin
  • Guarantee spotless skin or a specified number of sessions
  • Release a professional high-concentration peel for self-application

Superficial, medium-depth and deep peels are not interchangeable intensity levels. Wound, aftercare and complication framework all change with depth.

Diagnosis and activity before care

Five checks come before selection.

History, examination, current treatment, contraindications and a proportionate alternative are reviewed together.

  1. 01

    Clarify the problem

    Diagnosis, skin type, pigment and scar risk, infection, herpes history, medicines and previous procedures precede any peel.

  2. 02

    Review current treatment

    Medicines, allergies, previous procedures or infusions and relevant reactions are considered.

  3. 03

    Identify the exact option

    Agent, formulation, concentration, pH, layers or passes, contact time, neutralisation and intended depth are product- and protocol-specific.

  4. 04

    Compare alternatives

    Skin care, disease-directed treatment, microneedling, a device-based option, observation or no procedure

  5. 05

    Plan follow-up

    Urgent review is required for eye exposure, severe pain, blistering, spreading redness, discharge, delayed healing or marked colour change.

Before · during · after

Safety depends on a complete, documented chain.

Agent, formulation, concentration, pH, layers or passes, contact time, neutralisation and intended depth are product- and protocol-specific.

01Before

Confirm finding and skin state

Diagnosis, skin type, pigment and scar risk, infection, herpes history, medicines and previous procedures precede any peel.

  • Review history and examination
  • Check contraindications
  • Keep alternatives open
02During

Control exposure and response

Agent, formulation, concentration, pH, layers or passes, contact time, neutralisation and intended depth are product- and protocol-specific.

  • Maintain traceability
  • Monitor tolerance
  • Stop when safety changes
03After

Separate expected response from harm

Urgent review is required for eye exposure, severe pain, blistering, spreading redness, discharge, delayed healing or marked colour change.

  • Record observations
  • Explain warning signs
  • Provide a review route

No personal acid concentration, contact time, prescription medicine or home-treatment recipe is published.

Method-, product- and indication-specific

Biology or popularity is not proof of clinical benefit.

Benefits and harms cannot be generalised across peel depths, formulations, diagnoses or skin types.

01

Keep the indication exact

Evidence in one diagnosis or deficiency does not establish a general effect.

02

Keep the intervention exact

Agent, formulation, concentration, pH, layers or passes, contact time, neutralisation and intended depth are product- and protocol-specific.

03

Keep endpoints separate

Symptoms, photographs, laboratory values and patient-reported outcomes are not interchangeable.

04

Retain uncertainty

Deep peels may require anaesthesia or systemic monitoring and must not be presented as ordinary skin care.

Manufacturer information may identify a product and instructions, but it is not treated as independent evidence of a general class effect.

No automatic peel series

Heal safely first, then decide again.

The first peel has a limited aim. Skin response and healing determine whether to repeat, change or stop.

01

Record the baseline

Document the diagnosis, phototype, target area and pigmentation status.

02

Limit the depth

Choose the mildest suitable protocol for the defined aim.

03

Monitor healing

Follow the wound, redness, pigmentation and symptoms separately.

04

Decide again

Repeat, change, pause or end the method.

Expected response · complication · reassessment

Repetition is never automatic.

Tolerance and the agreed clinical endpoint are reviewed separately before any further intervention.

  1. 01Before

    Baseline

    Record the starting clinical context and intended endpoint.

  2. 02Same day

    Immediate review

    Observe tolerance and unexpected reactions.

  3. 03Later

    Clinical review

    Compare the relevant finding without automatic attribution.

  4. 04Decision

    Continue, change or stop

    Urgent review is required for eye exposure, severe pain, blistering, spreading redness, discharge, delayed healing or marked colour change.

Actively prevent chemical burns

Peel depth and aftercare determine the risk.

Possible complications include chemical burns, infection, herpes reactivation, persistent redness, hyperpigmentation or hypopigmentation and scarring.

01Suitability

Stabilise first

Active infection, open skin, marked inflammation or a recent tan may require postponement.

02Colour

Protect pigmentation

Phototype, a history of melasma or PIH and photoprotection change the risk assessment.

03Aftercare

Do not manipulate the wound

Rubbing, removing crusts, using active ingredients too early or unprotected sun exposure can disrupt healing.

04Acute

Obtain immediate assessment

Severe pain, blisters, a weeping wound, fever or rapidly darkening discolouration are warning signs.

Unexpectedly severe or worsening symptoms need timely local examination. Photographs or messages do not replace wound and infection assessment.

Assessment and review must travel together

International care needs a workable safety route.

Travel does not shorten observation or remove the need for local medical access.

01

Organise the question

History and existing records prepare discussion without confirming treatment.

02

Assess in person

Diagnosis, skin type, pigment and scar risk, infection, herpes history, medicines and previous procedures precede any peel.

03

Keep exact records

Agent, formulation, concentration, pH, layers or passes, contact time, neutralisation and intended depth are product- and protocol-specific.

04

Plan escalation

Urgent review is required for eye exposure, severe pain, blistering, spreading redness, discharge, delayed healing or marked colour change.

Dr İsmail Aslan wearing a white medical coat
Dr İsmail AslanMedical DoctorClinical Focus: Hair Transplantation · Aesthetic Medicine

Medical position

As superficial as possible, as targeted as necessary.

Dr İsmail Aslan does not plan chemical peels by trend names or the desired amount of peeling. Diagnosis, skin phototype, documented product, controlled endpoint and reliable aftercare must fit together.

01

Diagnosis before acid

A pigmented mark or scar is medically classified before the method is chosen.

02

Protocol instead of percentage

Concentration is assessed only together with pH, formulation, time, layers and endpoint.

03

Limit the depth

More peeling does not automatically mean more benefit, but it does create a different healing risk.

04

Aftercare as a prerequisite

Treatment is not planned without suitable photoprotection, wound care and accessible review.

Medical responsibility: Dr İsmail AslanMedical review: 24 August 2026General patient information about Chemical Peel; no personal prescription or outcome guarantee

Short and clear

Questions commonly asked before a decision.

These answers provide general orientation and do not replace personal diagnosis or treatment planning.

01What determines the actual depth of a chemical peel?

Not the acid name or percentage alone. Agent, concentration, pH, vehicle, applied quantity, number of layers, contact time, skin preparation, anatomical region and observed endpoint influence penetration. Superficial, medium-depth and deep peels are therefore planned as different medical procedures.

02Can a high-concentration acid peel be used safely at home?

No. Depending on concentration, layers and contact time, high-strength glycolic, salicylic, lactic or trichloroacetic acid can cause an uncontrolled chemical burn. Pain, infection, pigment change and scarring are possible. A professional peel protocol is not for self-application.

03Why is pigmentation risk assessed especially carefully before a peel?

Any controlled inflammation may cause post-inflammatory hyperpigmentation; deeper peels can also cause lightening. Phototype, a history of melasma or PIH, tanning, active inflammation and photoprotection affect risk. Darker skin is not an automatic exclusion, but requires appropriate experience and a conservative protocol.

04How is a chemical peel planned for travel to Istanbul?

Photographs, aim, medicines, previous peels, herpes, scar and pigment reactions, and sun exposure can be organised online. Diagnosis and peel depth are decided only after in-person examination; skin preparation, the visible healing window, early review, return travel, warning signs and a local medical contact are agreed in advance.

Define the question · verify the option · compare alternatives

Is Chemical Peel a reasonable route to assess?

Online Pre-Assessment can organise the clinical question and relevant history. It cannot diagnose or create a personal treatment protocol.